Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,967 | 250 | 62.1% |
| Travel and Lodging | $2,987 | 12 | 37.3% |
| Education | $47.63 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,598 | 29 | $0 (2024) |
| Abbott Laboratories | $1,658 | 12 | $0 (2024) |
| PFIZER INC. | $1,127 | 105 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $578.32 | 34 | $0 (2024) |
| Medtronic Vascular, Inc. | $509.99 | 6 | $0 (2018) |
| ATRICURE, INC. | $282.89 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $260.92 | 16 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $234.31 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $206.88 | 12 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $160.62 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,982 | 35 | Abbott Laboratories ($1,643) |
| 2023 | $233.10 | 11 | ATRICURE, INC. ($61.44) |
| 2022 | $454.50 | 21 | AtriCure, Inc. ($202.26) |
| 2021 | $655.06 | 37 | PFIZER INC. ($204.23) |
| 2020 | $458.44 | 19 | Boston Scientific Corporation ($175.33) |
| 2019 | $488.11 | 39 | PFIZER INC. ($202.13) |
| 2018 | $1,479 | 47 | BOSTON SCIENTIFIC CORPORATION ($1,035) |
| 2017 | $1,252 | 55 | Medtronic Vascular, Inc. ($492.02) |
All Payment Transactions
264 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: LUX-Dx_CRM | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.20 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/30/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $386.95 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/22/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $125.46 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/20/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $40.15 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: LUX-Dx_CRM | ||||||
| 07/31/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $156.90 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/31/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $115.71 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/31/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: LUX-Dx_CRM | ||||||
| 07/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $123.86 | General |
| 07/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/03/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $287.47 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/03/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $283.70 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Diabetes | ||||||
| 06/21/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $122.52 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/21/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $58.97 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,339 | 2,076 | $426,395 | $127,910 |
| 2022 | 31 | 2,205 | 3,176 | $418,370 | $127,107 |
| 2021 | 34 | 1,921 | 2,475 | $446,210 | $141,365 |
| 2020 | 32 | 1,656 | 2,141 | $418,572 | $127,396 |
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 285 | 415 | $51,875 | $25,758 | 49.7% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 22 | 24 | $69,240 | $17,220 | 24.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 91 | 156 | $24,960 | $8,987 | 36.0% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 22 | 22 | $29,810 | $8,685 | 29.1% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 13 | 13 | $26,715 | $7,839 | 29.3% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 12 | 12 | $28,260 | $7,772 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 83 | $16,450 | $7,642 | 46.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $11,275 | $5,086 | 45.1% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 32 | 164 | $18,040 | $4,207 | 23.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 52 | 53 | $17,225 | $3,325 | 19.3% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 33 | 43 | $10,535 | $3,302 | 31.3% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 28 | 149 | $10,430 | $2,677 | 25.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 161 | 253 | $18,975 | $2,553 | 13.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $5,800 | $2,515 | 43.4% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 32 | 43 | $7,525 | $2,367 | 31.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 57 | 100 | $17,000 | $2,359 | 13.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 47 | 61 | $6,710 | $1,965 | 29.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 35 | 48 | $4,800 | $1,827 | 38.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 72 | 126 | $10,710 | $1,783 | 16.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 27 | $4,725 | $1,671 | 35.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 30 | 30 | $5,250 | $1,531 | 29.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $4,550 | $1,425 | 31.3% |
| 93641 | Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | Facility | 2023 | 11 | 11 | $9,295 | $1,190 | 12.8% |
| 93291 | Evaluation of cardiac rhythm monitor system | Office | 2023 | 24 | 35 | $3,150 | $1,165 | 37.0% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 11 | 18 | $2,430 | $827.26 | 34.0% |
About Dr. Gary Langieri, MD
Dr. Gary Langieri, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Wilkes-Barre, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336139724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Langieri, MD has received a total of $8,001 in payments from pharmaceutical and medical device companies, with $2,982 received in 2024. These payments were reported across 264 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,967).
As a Medicare-enrolled provider, Langieri has provided services to 7,121 Medicare beneficiaries, totaling 9,868 services with total Medicare billing of $523,779. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Location Wilkes-Barre, PA
- Active Since 10/26/2005
- Last Updated 07/29/2021
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1336139724
Products in Payments
- AVEIR (Device) $1,643
- WATCHMAN (Device) $1,345
- ELIQUIS (Drug) $1,080
- WATCHMAN FLX (Device) $756.41
- LifeVest (Device) $578.32
- Micra (Device) $492.02
- CHANTIX (Drug) $270.88
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) (Device) $208.44
- MULTAQ (Drug) $206.88
- ENTRESTO (Drug) $168.44
- XARELTO (Drug) $160.62
- RHYTHMIA MAPPING SYSTEM (Device) $97.63
- NORTHERA (Drug) $89.29
- LEQVIO (Drug) $65.87
- LUX-Dx Insertable Cardiac Monitor (Device) $55.63
- SYNERGY ABLATION SYSTEM (Device) $55.26
- Corlanor (Drug) $50.16
- VIAGRA (Drug) $37.12
- LINQ II (Device) $35.67
- Ozempic (Drug) $34.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.